JPH06504782A - ベンズアミド - Google Patents
ベンズアミドInfo
- Publication number
- JPH06504782A JPH06504782A JP4503280A JP50328092A JPH06504782A JP H06504782 A JPH06504782 A JP H06504782A JP 4503280 A JP4503280 A JP 4503280A JP 50328092 A JP50328092 A JP 50328092A JP H06504782 A JPH06504782 A JP H06504782A
- Authority
- JP
- Japan
- Prior art keywords
- cyclopentyloxy
- methoxybenzamide
- general formula
- compound
- melting point
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C65/21—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups
- C07C65/24—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups polycyclic
- C07C65/26—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups polycyclic containing rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/56—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/57—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and carboxyl groups, other than cyano groups, bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/58—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
- C07C255/60—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton at least one of the singly-bound nitrogen atoms being acylated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/45—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the singly-bound nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfonamides
- C07C311/46—Y being a hydrogen or a carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C317/32—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C317/34—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring
- C07C317/38—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring with the nitrogen atom of at least one amino group being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfones
- C07C317/40—Y being a hydrogen or a carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
- C07C323/40—Y being a hydrogen or a carbon atom
- C07C323/42—Y being a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C327/00—Thiocarboxylic acids
- C07C327/38—Amides of thiocarboxylic acids
- C07C327/48—Amides of thiocarboxylic acids having carbon atoms of thiocarboxamide groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
- C07C2602/42—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing seven carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
- Body Structure For Vehicles (AREA)
- Hydrogenated Pyridines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1、一般式 ▲数式、化学式、表等があります▼(I)式中、R1は4個までの炭素原子を含 有する直鎖状もしくは分枝鎖状のアルキルであり、R2は2〜15個の炭素原子 を含有する直鎖状もしくは分枝鎖状のアルキルまたは10個までの炭素原子を含 有するモノ−、ビーまたはトリシクロアルキルであり、R3は置換されていても よいフェニル、ナフチルまたはヘテロサイクルの基であり、そしてZは酸素また は硫黄である、 のベンズアミド誘導体、および前記ヘテロサイクル基が1または2以上の窒素の 環原子を含有するとき、それらのN−オキシド、およびそれらの製剤学的に許容 される塩。 2、ヘテロサイクル基は酸素、硫黄および窒素の原子を含有する1または2以上 の異種原子を含有する5、6または7員のヘテロサイクル基であり、そしてフェ ニル、ナフチルまたはヘテロサイクル上の任意の置換基はハロゲン原子、1また は2以上のハロゲン原子を有することができるアルキル基から、およびアリール 、アリールアルキル、アルコキシ、アリールオキシ、アルキルチオ、アリールチ オ、アルコキシカルボニル、アリールオキシカルボニル、アルカノイル、アロイ ル、アルキルスルホニル、アリールスルホニル、アルキルスルフィニル、アリー ルスルフィニル、ヒドロキシ、ヒドロキシアルキル、ホルミル、アルカノイルア ミノ、アロイルアミノ、シアノおよびニトロ基から、およびアミノ、カルバモイ ルおよびスルファモイル基(これらの基の各々は1または2つのアルキル置換基 を有することができる)から選択され、ここですべてのアリールの基および部分 は、特記しない限り、ハロゲン原子およびアルキルおよびアルコキシ基から選択 される1または2以上の置換基で置換されていてもよいフェニルおよびナフチル 基から選択され、そしてここですべてのアルキルの基および部分は、特記しない 限り、直鎖状もしくは分枝鎖状でありかつ4個までの炭素原子を含有する、請求 の範囲1に記載の化合物。 3、R2は2〜12個の炭素原子を含有する直鎖状もしくは分枝鎖状のアルキル 基である、請求の範囲1または2に記載の化合物。 4、記号の少なくとも1つは、 (i)R1はメチル基である、 (ii)R2はプロピル、ブチル、ノニル、ドデシル、シクロヘキシル、8,9 ,10−トリノルポリニルまたはシクロペンチル基である、および/または (iii)R3は置換されていてもよいピラジニル、ピリミジニル、イソキサゾ リルまたはピリジル基、またはそれらのN−オキシド、または置換されていても よいフェニル基である、から選択される意味を有し、他の記号は上に定義した通 りである、請求の範囲1に記載の化合物。 5、R2はシクロペンチルであり、そしてk3は置換されていてもよいピリジル である、請求の範囲4に記載の化合物。 6、R3は2−位置において、あるいは2−および6−位置において置換されて いるフェニル基である、請求の範囲1〜5項のいずれかに記載の化合物。 7、R3は分子の残部への結合点に隣接する位置の一方または両者上で置換され たヘテロサイクル基である、請求の範囲1〜5項のいずれかに記載の化合物。 8、A〜BXまたはそれらの製剤学的に許容される塩として上に識別した請求の 範囲1に記載の化合物。 9、(a)一般式(II): ▲数式、化学式、表等があります▼(II)式中R1およびR2は請求の範囲1 において定義した通りであり、そしてX1はハロゲン原子である、 の化合物を、一般式(III) NH2R3(III) 式中R3は請求の範囲1において定義した通りである、の化合物と反応させるか 、あるいは (b)一般式(IV): ▲数式、化学式、表等があります▼(IV)式中R1、R3およびZは請求の範 囲1において定義した通りである、の化合物を、一般式(V): R2X2(V) 式中R2は請求の範囲1において定義した通りであり、そしてX2はハロゲン原 子である、 の化合物と反応させ、 必要に応じてこうして得られた一般式(I)の化合物を一般式(I)の他の化合 物に転化し、 そして必要に応じてこうして得られた一般式(I)の化合物をその塩に転化する 、 ことからなる、請求の範囲1に記載の化合物を調製する方法。 10、請求の範囲1において定義した一般式(I)のべンズアミド誘導体または その製剤学的に許容される塩および製剤学的に許容されうる担体またはコーティ ングからなる製剤学的組成物。 11、有効量の請求の範囲1において定義した一般式(I)のべンズアミド誘導 体またはその製剤学的に許容される塩を投与することからなる、環状AMPホス ホジエステラーゼのインヒビターの投与により改善することができる状態に悩ま されるか、あるいはその状態にあるヒトまたは動物を処直する方法。
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB919101777A GB9101777D0 (en) | 1991-01-28 | 1991-01-28 | New compositions of matter |
GB9117727.9 | 1991-08-16 | ||
GB9101777.2 | 1991-08-16 | ||
GB919117727A GB9117727D0 (en) | 1991-08-16 | 1991-08-16 | New compositions of matter |
PCT/GB1992/000153 WO1992012961A1 (en) | 1991-01-28 | 1992-01-28 | Benzamides |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH06504782A true JPH06504782A (ja) | 1994-06-02 |
JP2664538B2 JP2664538B2 (ja) | 1997-10-15 |
Family
ID=26298343
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP4503280A Expired - Lifetime JP2664538B2 (ja) | 1991-01-28 | 1992-01-28 | ベンズアミド |
Country Status (20)
Country | Link |
---|---|
EP (3) | EP0669311B1 (ja) |
JP (1) | JP2664538B2 (ja) |
AT (2) | ATE165334T1 (ja) |
AU (2) | AU664694B2 (ja) |
CA (1) | CA2101423C (ja) |
CZ (1) | CZ281894B6 (ja) |
DE (2) | DE69207017T2 (ja) |
DK (1) | DK0497564T3 (ja) |
ES (1) | ES2081563T3 (ja) |
FI (1) | FI933357A (ja) |
GR (1) | GR3018544T3 (ja) |
HU (2) | HUT64942A (ja) |
IE (1) | IE71647B1 (ja) |
IL (1) | IL100788A (ja) |
MX (1) | MX9200344A (ja) |
NO (1) | NO932701L (ja) |
NZ (1) | NZ241427A (ja) |
SK (1) | SK80993A3 (ja) |
TW (1) | TW274541B (ja) |
WO (1) | WO1992012961A1 (ja) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000229920A (ja) * | 1999-02-12 | 2000-08-22 | Otsuka Pharmaceut Co Ltd | アミド誘導体の製造方法 |
JP2007532584A (ja) * | 2004-04-08 | 2007-11-15 | ワイス | 3−シクロペンチルオキシ−4−メトキシベンズアルデヒドの製造方法 |
JP2014501763A (ja) * | 2010-12-22 | 2014-01-23 | ザ トラスティーズ オブ コロンビア ユニヴァーシティ イン ザ シティ オブ ニューヨーク | ヒストンアセチル基転移酵素モジュレーターおよびその使用 |
US11034647B2 (en) | 2009-12-10 | 2021-06-15 | The Trustees Of Columbia University In The City Of New York | Histone acetyltransferase activators and uses thereof |
Families Citing this family (106)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9311281D0 (en) * | 1993-06-01 | 1993-07-21 | Rhone Poulenc Rorer Ltd | Novel composition of matter |
US5698711A (en) * | 1991-01-28 | 1997-12-16 | Rhone-Poulenc Rorer Limited | Compounds containing phenyl linked to aryl or heteroaryl by an aliphatic- or heteroatom-containing linking group |
GB9204808D0 (en) * | 1992-03-04 | 1992-04-15 | Rhone Poulenc Rorer Ltd | Novel compositions of matter |
EP0607373B1 (en) * | 1992-06-15 | 1997-03-19 | Celltech Therapeutics Limited | Trisubstituted phenyl derivatives as selective phosphodiesterase iv inhibitors |
GB9212693D0 (en) * | 1992-06-15 | 1992-07-29 | Celltech Ltd | Chemical compounds |
GB9212673D0 (en) * | 1992-06-15 | 1992-07-29 | Celltech Ltd | Chemical compounds |
US5679696A (en) * | 1992-07-28 | 1997-10-21 | Rhone-Poulenc Rorer Limited | Compounds containing phenyl linked to aryl or heteroaryl by an aliphatic-or heteroatom-containing linking group |
WO1994002465A1 (en) * | 1992-07-28 | 1994-02-03 | Rhone-Poulenc Rorer Limited | INHIBITORS OF c-AMP PHOSPHODIESTERASE AND TNF |
GB2269992A (en) * | 1992-08-14 | 1994-03-02 | Rh Ne Poulenc Rorer Limited | Powder inhalation formulations |
GB9222253D0 (en) * | 1992-10-23 | 1992-12-09 | Celltech Ltd | Chemical compounds |
GB9304920D0 (en) * | 1993-03-10 | 1993-04-28 | Celltech Ltd | Chemical compounds |
GB9304919D0 (en) * | 1993-03-10 | 1993-04-28 | Celltech Ltd | Chemical compounds |
GB9311282D0 (en) * | 1993-06-01 | 1993-07-21 | Rhone Poulenc Rorer Ltd | New compositions of matter |
GB9312853D0 (en) | 1993-06-22 | 1993-08-04 | Euro Celtique Sa | Chemical compounds |
JP3093271B2 (ja) * | 1993-07-02 | 2000-10-03 | ビイク グルデン ロンベルク ヒェーミッシェ ファブリーク ゲゼルシャフト ミット ベシュレンクテル ハフツング | フルオルアルコキシ置換のベンズアミド及び環状ヌクレオチドホスホジエステラーゼ阻害剤としてのその使用 |
GB9315595D0 (en) * | 1993-07-28 | 1993-09-08 | Res Inst Medicine Chem | New compounds |
ATE218549T1 (de) * | 1993-07-28 | 2002-06-15 | Aventis Pharma Ltd | Verbindungen als pde iv und tnf inhibitoren |
US5665754A (en) * | 1993-09-20 | 1997-09-09 | Glaxo Wellcome Inc. | Substituted pyrrolidines |
US5502072A (en) * | 1993-11-26 | 1996-03-26 | Pfizer Inc. | Substituted oxindoles |
EP0738268B1 (en) * | 1993-12-22 | 2004-03-03 | Celltech R&D Limited | Trisubstituted phenyl derivatives, processes for their preparation and their use as phosphodiesterase (type iv) inhibitors |
GB9326173D0 (en) * | 1993-12-22 | 1994-02-23 | Celltech Ltd | Chemical compounds and process |
GB9401460D0 (en) * | 1994-01-26 | 1994-03-23 | Rhone Poulenc Rorer Ltd | Compositions of matter |
US5786354A (en) * | 1994-06-21 | 1998-07-28 | Celltech Therapeutics, Limited | Tri-substituted phenyl derivatives and processes for their preparation |
US6245774B1 (en) | 1994-06-21 | 2001-06-12 | Celltech Therapeutics Limited | Tri-substituted phenyl or pyridine derivatives |
GB9412573D0 (en) | 1994-06-22 | 1994-08-10 | Celltech Ltd | Chemical compounds |
GB9412571D0 (en) | 1994-06-22 | 1994-08-10 | Celltech Ltd | Chemical compounds |
GB9412672D0 (en) * | 1994-06-23 | 1994-08-10 | Celltech Ltd | Chemical compounds |
US5591776A (en) * | 1994-06-24 | 1997-01-07 | Euro-Celtique, S.A. | Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV |
US5922751A (en) * | 1994-06-24 | 1999-07-13 | Euro-Celtique, S.A. | Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same |
MX9700557A (es) * | 1994-07-22 | 1997-12-31 | Byk Gulden Lomberg Chem Fab | Dihidrobenzofuranos. |
US5665737B1 (en) * | 1994-10-12 | 1999-02-16 | Euro Celtique Sa | Substituted benzoxazoles |
TW334337B (en) * | 1994-11-07 | 1998-06-21 | Novartis Ag | Preparation and composition for a compound of controlling and preventing phytopathogenic fungi |
US6025361A (en) * | 1994-12-13 | 2000-02-15 | Euro-Celtique, S.A. | Trisubstituted thioxanthines |
AU4527896A (en) * | 1994-12-13 | 1996-07-03 | Euro-Celtique S.A. | Aryl thioxanthines |
GB9507297D0 (en) * | 1995-04-07 | 1995-05-31 | Rh Ne Poulenc Rorer Limited | New composition of matter |
AU5772296A (en) * | 1995-05-19 | 1996-11-29 | Chiroscience Limited | 3,4-disubstituted-phenylsulphonamides and their therapeutic use |
WO1996036596A1 (en) * | 1995-05-19 | 1996-11-21 | Chiroscience Limited | 3,4-disubstituted-phenylsulphonamides and their therapeutic use |
WO1996040636A1 (en) * | 1995-06-07 | 1996-12-19 | Pfizer Inc. | Catechol diethers derivatives useful as pharmaceutical agents |
US6268373B1 (en) | 1995-06-07 | 2001-07-31 | Euro-Celtique S.A. | Trisubstituted thioxanthines |
AU6526896A (en) * | 1995-07-22 | 1997-02-18 | Rhone-Poulenc Rorer Limited | Substituted aromatic compounds and their pharmaceutical use |
GB9523675D0 (en) * | 1995-11-20 | 1996-01-24 | Celltech Therapeutics Ltd | Chemical compounds |
GB9526245D0 (en) * | 1995-12-21 | 1996-02-21 | Celltech Therapeutics Ltd | Chemical compounds |
GB9526246D0 (en) * | 1995-12-21 | 1996-02-21 | Celltech Therapeutics Ltd | Chemical compounds |
US6075016A (en) | 1996-04-10 | 2000-06-13 | Euro-Celtique S.A. | 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity |
GB9608435D0 (en) * | 1996-04-24 | 1996-06-26 | Celltech Therapeutics Ltd | Chemical compounds |
US5864037A (en) * | 1996-06-06 | 1999-01-26 | Euro-Celtique, S.A. | Methods for the synthesis of chemical compounds having PDE-IV inhibitory activity |
EP0934307B1 (en) | 1996-06-19 | 2011-04-27 | Aventis Pharma Limited | Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase |
GB9619284D0 (en) * | 1996-09-16 | 1996-10-30 | Celltech Therapeutics Ltd | Chemical compounds |
US5744473A (en) * | 1996-09-16 | 1998-04-28 | Euro-Celtique, S.A. | PDE IV inhibitors: "bis-compounds" |
GB9622363D0 (en) | 1996-10-28 | 1997-01-08 | Celltech Therapeutics Ltd | Chemical compounds |
US5958926A (en) * | 1996-11-01 | 1999-09-28 | Nitromed, Inc. | Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
AU3709897A (en) * | 1996-11-28 | 1998-06-22 | Cheil Jedang Corporation | Cathecol derivatives and a method for the preparation thereof and a pharmaceutical composition containing the same |
GB9625184D0 (en) * | 1996-12-04 | 1997-01-22 | Celltech Therapeutics Ltd | Chemical compounds |
WO1998028281A1 (en) * | 1996-12-23 | 1998-07-02 | Celltech Therapeutics Limited | Fused polycyclic 2-aminopyrimidine derivatives, their preparation and their use as protein tyrosine kinase inhibitors |
ATE292622T1 (de) * | 1997-01-22 | 2005-04-15 | Aventis Pharma Inc | Substituierte beta-thiocarbonsäuren |
GB9705361D0 (en) | 1997-03-14 | 1997-04-30 | Celltech Therapeutics Ltd | Chemical compounds |
GB9713087D0 (en) * | 1997-06-20 | 1997-08-27 | Celltech Therapeutics Ltd | Chemical compounds |
KR100540046B1 (ko) | 1997-11-12 | 2006-01-10 | 미쓰비시 가가꾸 가부시키가이샤 | 퓨린유도체 및 이를 유효성분으로 함유하는 의약 |
US6303645B1 (en) | 1998-05-22 | 2001-10-16 | Avanir Pharmaceuticals | Benzimidazole derivatives as modulators of IgE |
US6911462B2 (en) | 1998-05-22 | 2005-06-28 | Avanir Pharmaceuticals | Benzimidazole compounds for regulating IgE |
US6369091B1 (en) | 1998-05-22 | 2002-04-09 | Avanir Pharmaceuticals | Benzimidazole analogs as down-regulators of IgE |
US6919366B2 (en) | 1998-05-22 | 2005-07-19 | Avanir Pharmaceuticals | Benzimidazole derivatives as modulators of IgE |
BR9910641A (pt) | 1998-05-22 | 2001-10-02 | Avanir Pharmaceuticals | Derivados de benzimidazol como moduladores de ige |
RU2235095C2 (ru) | 1998-10-06 | 2004-08-27 | Дайниппон Фармасьютикал Ко., Лтд. | 2,3-дизамещенное производное пиридина, способы его получения, содержащая его фармацевтическая композиция и промежуточный продукт для его получения |
EP1178046B1 (en) | 1999-05-11 | 2003-11-19 | Mitsubishi Chemical Corporation | Purine derivative dihydrate, drugs containing the same as the active ingredient and intermediate in the production thereof |
KR100473967B1 (ko) * | 1999-05-25 | 2005-03-07 | 씨제이 주식회사 | 캐테콜 카르복실아미드 유도체 및 그를 함유한 약제학적 조성물 |
GB9914258D0 (en) | 1999-06-18 | 1999-08-18 | Celltech Therapeutics Ltd | Chemical compounds |
NZ517166A (en) | 1999-08-21 | 2004-01-30 | Altana Pharma Ag | Synergistic combination of PDE inhibitors and beta 2 adrenoceptor agonists |
GB9924862D0 (en) | 1999-10-20 | 1999-12-22 | Celltech Therapeutics Ltd | Chemical compounds |
US6759425B2 (en) | 1999-10-21 | 2004-07-06 | Avanir Pharmaceuticals | Benzimidazole compounds for modulating IgE and inhibiting cellular proliferation |
US7217722B2 (en) | 2000-02-01 | 2007-05-15 | Kirin Beer Kabushiki Kaisha | Nitrogen-containing compounds having kinase inhibitory activity and drugs containing the same |
CA2402384A1 (en) | 2000-03-16 | 2001-09-20 | Inflazyme Pharmaceuticals Ltd. | Benzylated pde4 inhibitors |
JP2003534328A (ja) * | 2000-05-25 | 2003-11-18 | メルク フロスト カナダ アンド カンパニー | フルオロアルコキシ置換ベンズアミドジクロロピリジニルn−オキシドpde4阻害剤 |
BR0208010A (pt) | 2001-03-12 | 2004-12-21 | Avanir Pharmaceuticals | Composto de benzimidazol para modulação de ige e inibição de proliferação celular |
MXPA03010672A (es) | 2001-05-23 | 2004-03-02 | Tanabe Seiyaku Co | Composicion para el tratamiento regenerativo de enfermedades del cartilago. |
EP1389468A4 (en) | 2001-05-23 | 2007-01-10 | Tanabe Seiyaku Co | COMPOSITIONS PROMOTING THE GUISON OF A BONE FRACTURE |
PL367130A1 (en) | 2001-05-29 | 2005-02-21 | Schering Aktiengesellschaft | Cdk inhibiting pyrimidines, production thereof and their use as medicaments |
MY140561A (en) | 2002-02-20 | 2009-12-31 | Nycomed Gmbh | Dosage form containing pde 4 inhibitor as active ingredient |
WO2004022536A1 (en) * | 2002-09-04 | 2004-03-18 | Glenmark Pharmaceuticals Limited | New heterocyclic amide compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
TWI276631B (en) | 2002-09-12 | 2007-03-21 | Avanir Pharmaceuticals | Phenyl-aza-benzimidazole compounds for modulating IgE and inhibiting cellular proliferation |
WO2004024655A2 (en) | 2002-09-12 | 2004-03-25 | Avanir Pharmaceuticals | Phenyl-indole compounds for modulating ige and inhibiting cellular proliferation |
US6822114B1 (en) | 2002-10-08 | 2004-11-23 | Albemarle Corporation | Process for production of fluoroalkoxy-substituted benzamides and their intermediates |
KR20050065624A (ko) | 2002-10-23 | 2005-06-29 | 그렌마크 파머수티칼스 엘티디. | 염증성 및 알레르기 질환의 치료에 유용한 신규한트리사이클릭 화합물, 이의 제조 방법 및 이를 함유하는약제 조성물 |
US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
AU2004226353A1 (en) | 2003-04-01 | 2004-10-14 | Laboratoires Serono Sa | Inhibitors of phosphodiesterases in infertility |
SI1620429T1 (sl) | 2003-04-11 | 2009-08-31 | Glenmark Pharmaceuticals Sa | Nove heterociklične spojine, uporabne za zdravljenje vnetnih in alergijskih motenj: postopek za njihovo pripravo in farmacevtski sestavki, ki jih vsebujejo |
CA2583497A1 (en) | 2004-10-13 | 2006-04-20 | Glenmark Pharmaceuticals S.A. | Process for the preparation of n-(3,5-dichloropyrid-4-yl)-4difluoromethoxy-8-methanesulfonamido-dibenzo[b,d]furan-1-carboxamide |
KR101317119B1 (ko) | 2004-12-17 | 2013-10-11 | 그렌마크 파머수티칼스 에스. 아. | 염증성 및 알레르기성 장애의 치료에 유용한 신규한헤테로사이클릭 화합물 |
PT1831227E (pt) | 2004-12-17 | 2013-08-23 | Glenmark Pharmaceuticals Sa | Proteínas buganina modificadas, citotoxinas e métodos e utilizações das mesmas |
EP1879884B1 (en) * | 2005-05-03 | 2010-08-25 | Ranbaxy Laboratories Limited | Azole-based phosphodiesterase inhibitors |
JP5529010B2 (ja) | 2007-05-16 | 2014-06-25 | タケダ ゲゼルシャフト ミット ベシュレンクテル ハフツング | Pde4インヒビターとしてのピラゾロン誘導体 |
US8034782B2 (en) | 2008-07-16 | 2011-10-11 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
CA3089569C (en) | 2007-06-04 | 2023-12-05 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
CA2930674A1 (en) | 2008-06-04 | 2009-12-10 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
CA2828346C (en) | 2011-03-01 | 2021-01-26 | Synergy Pharmaceuticals Inc. | Process of preparing guanylate cyclase c agonists |
WO2013084182A1 (en) | 2011-12-08 | 2013-06-13 | Glenmark Pharmaceuticals S.A. | Pharmaceutical composition that includes a pde4 enzyme inhibitor and an analgesic agent |
US9545446B2 (en) | 2013-02-25 | 2017-01-17 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase and their uses |
EP2968439A2 (en) | 2013-03-15 | 2016-01-20 | Synergy Pharmaceuticals Inc. | Compositions useful for the treatment of gastrointestinal disorders |
AU2014235215A1 (en) | 2013-03-15 | 2015-10-01 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
JP6606491B2 (ja) | 2013-06-05 | 2019-11-13 | シナジー ファーマシューティカルズ インコーポレイテッド | グアニル酸シクラーゼcの超高純度アゴニスト、その作成および使用方法 |
CN105979959B (zh) | 2013-08-09 | 2021-11-30 | 阿德利克斯公司 | 用于抑制磷酸盐转运的化合物和方法 |
EP3165224A1 (en) | 2015-11-09 | 2017-05-10 | Albert-Ludwigs-Universität Freiburg | Use of pde4 inhibitors for the prophylaxis and/or therapy of dyslipoproteinaemia and related disorders |
WO2017089347A1 (en) | 2015-11-25 | 2017-06-01 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Methods and pharmaceutical compositions for the treatment of braf inhibitor resistant melanomas |
US20200368223A1 (en) | 2019-05-21 | 2020-11-26 | Ardelyx, Inc. | Methods for inhibiting phosphate transport |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5869812A (ja) | 1981-10-22 | 1983-04-26 | Chugai Pharmaceut Co Ltd | 血糖降下剤 |
JPS62158252A (ja) * | 1985-12-28 | 1987-07-14 | Kirin Brewery Co Ltd | 4−アミノピリジンベンズアミド誘導体 |
HU215441B (hu) | 1989-11-13 | 1999-04-28 | Pfizer Inc. | Eljárás az endo-biciklo [2.2.1]-heptan-2-ol előállítására és az ebből kapott hatóanyagok enzimatikus úton történő elválasztására |
-
1992
- 1992-01-27 IE IE920247A patent/IE71647B1/en not_active IP Right Cessation
- 1992-01-28 JP JP4503280A patent/JP2664538B2/ja not_active Expired - Lifetime
- 1992-01-28 MX MX9200344A patent/MX9200344A/es unknown
- 1992-01-28 TW TW081100612A patent/TW274541B/zh active
- 1992-01-28 CZ CS931528A patent/CZ281894B6/cs unknown
- 1992-01-28 EP EP95106899A patent/EP0669311B1/en not_active Expired - Lifetime
- 1992-01-28 DK DK92300726.4T patent/DK0497564T3/da active
- 1992-01-28 IL IL10078892A patent/IL100788A/xx not_active IP Right Cessation
- 1992-01-28 NZ NZ241427A patent/NZ241427A/en unknown
- 1992-01-28 CA CA002101423A patent/CA2101423C/en not_active Expired - Lifetime
- 1992-01-28 EP EP92300726A patent/EP0497564B1/en not_active Expired - Lifetime
- 1992-01-28 AT AT95106899T patent/ATE165334T1/de not_active IP Right Cessation
- 1992-01-28 DE DE69207017T patent/DE69207017T2/de not_active Expired - Lifetime
- 1992-01-28 ES ES92300726T patent/ES2081563T3/es not_active Expired - Lifetime
- 1992-01-28 HU HU9302199A patent/HUT64942A/hu unknown
- 1992-01-28 AT AT92300726T patent/ATE132134T1/de not_active IP Right Cessation
- 1992-01-28 AU AU11881/92A patent/AU664694B2/en not_active Ceased
- 1992-01-28 SK SK809-93A patent/SK80993A3/sk unknown
- 1992-01-28 WO PCT/GB1992/000153 patent/WO1992012961A1/en active IP Right Grant
- 1992-01-28 DE DE69225245T patent/DE69225245D1/de not_active Expired - Lifetime
- 1992-01-28 EP EP92903462A patent/EP0569414A1/en active Pending
-
1993
- 1993-07-27 FI FI933357A patent/FI933357A/fi unknown
- 1993-07-27 NO NO93932701A patent/NO932701L/no unknown
-
1995
- 1995-06-30 HU HU95P/P00720P patent/HU211679A9/hu unknown
- 1995-12-28 GR GR950402648T patent/GR3018544T3/el unknown
-
1996
- 1996-02-21 AU AU45651/96A patent/AU4565196A/en not_active Abandoned
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000229920A (ja) * | 1999-02-12 | 2000-08-22 | Otsuka Pharmaceut Co Ltd | アミド誘導体の製造方法 |
JP2007532584A (ja) * | 2004-04-08 | 2007-11-15 | ワイス | 3−シクロペンチルオキシ−4−メトキシベンズアルデヒドの製造方法 |
US11034647B2 (en) | 2009-12-10 | 2021-06-15 | The Trustees Of Columbia University In The City Of New York | Histone acetyltransferase activators and uses thereof |
JP2014501763A (ja) * | 2010-12-22 | 2014-01-23 | ザ トラスティーズ オブ コロンビア ユニヴァーシティ イン ザ シティ オブ ニューヨーク | ヒストンアセチル基転移酵素モジュレーターおよびその使用 |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH06504782A (ja) | ベンズアミド | |
DE69418704T2 (de) | Anthranilsäure derivate | |
JP3953096B2 (ja) | サイクリックampホスホジエステラーゼおよびtnf阻害剤としての置換芳香族化合物 | |
DE69403823T2 (de) | Substituierte Phenylsulfonamine als selektive B3-Agonisten zur Behandlung von Diabetes und Fettleibigkeit | |
WO1989003818A1 (en) | Novel fenamic acid hydroxamate derivatives having cyclooxygenase and 5-lipoxygenase inhibition | |
EP0342682A2 (en) | Hydroxamate derivatives of selected nonsteroidal anti-inflammatory acyl residues having cyclooxygenase and 5-lipoxygenase inhibition | |
CA2555712C (en) | Novel cyclic compound having 4-pyridylalkylthio group having substituted or unsubstituted amino group introduced therein | |
PL164432B1 (pl) | Sposób wytwarzania nowych pochodnych aminofenolu PL | |
US11858919B2 (en) | HDAC1,2 inhibitors | |
IL98542A (en) | History of benzoquinazole preparation and pharmaceutical preparations containing them | |
HU218794B (hu) | Diamino-ciklobutén-3,4-dionok, előállításuk és ezeket tartalmazó gyógyszerkészítmények | |
WO1996034856A1 (en) | 2-ureido-benzamide derivatives | |
ES2262248T3 (es) | Nuevos compuestos amida y medicamente que los contienen. | |
JPH11269140A (ja) | 分化誘導剤 | |
JPS62149662A (ja) | N−含有複素環化合物 | |
JP4626353B2 (ja) | 置換又は無置換アミノ基を導入した4−ピリジルアルキルチオ基を有する新規環式化合物 | |
US5900426A (en) | Benzothiazole derivatives | |
DE3804346A1 (de) | Tert.-butylphenyl-pyridyl-amide - verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel | |
WO2009053999A2 (en) | Sulfoximine derivatives as factor xa inhibitors | |
EP0481891B1 (en) | Phenoxyacetic acid compounds, method for production thereof, and pharmaceutical preparations containing same | |
JPH10120681A (ja) | 新規アザインドール化合物 | |
PL169994B1 (pl) | Sposób wytwarzania nowych pochodnych benzamidu |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080620 Year of fee payment: 11 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090620 Year of fee payment: 12 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100620 Year of fee payment: 13 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110620 Year of fee payment: 14 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110620 Year of fee payment: 14 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120620 Year of fee payment: 15 |
|
EXPY | Cancellation because of completion of term | ||
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120620 Year of fee payment: 15 |